pillbase.ru

Ertapenem

Active substance: ertapenem

INJECTION · ERTAPENEM SODIUM 1 g/20mL

United StatesActive

Marketing holder: Apotex Corp

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 3
  • Ertapenem Hospira
    ertapenem sodium
    EMEA/H/C/004080
    Hospira UK Limited
  • Ertapenem SUN
    ertapenem
    EMEA/H/C/005815
    SUN Pharmaceutical Industries (Europe) B.V.
  • Invanz
    ertapenem sodium
    EMEA/H/C/000389
    Merck Sharp & Dohme B.V.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-03b8-78ff-9516-ad7e537da151,01a1208e-07e7-7c1a-8718-35dee4482362,01a1208f-db67-77ad-abc0-3bb759386d59,01a1208f-e8c0-74f4-a1c1-317e6d87761a,01a12090-4370-7ab8-b699-c6ffe1766965;count=18 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
60505-6196
Registration status
Active
Dispensing
Prescription only
Route
INTRAMUSCULAR, INTRAVENOUS
Sources
  • product · openFDA NDC · 60505-6196 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 60505-6196 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 60505-6196 · Verified 2026-10-09 · open in source